TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH HIGH WHITE CELL BLOOD COUNTS. by Lionel Ades, Charicleia Kelaidi, Pierre Fenaux

Get full text

TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH HIGH WHITE CELL BLOOD COUNTS. by Charicleia Kelaidi, Lionel Ades, Pierre Fenaux

Get full text

Modeling mesenchymal stromal cell support to hematopoiesis within a novel 3D artificial marrow organoid system by Bérénice Schell, Lin-Pierre Zhao, Inés M’Sibih, Maria Kalogeraki, Camille Kergaravat, Emilie Lereclus, Pierre Fenaux, Lionel Adès, Antoine Toubert, Marion Espéli, Karl Balabanian, Emmanuel Clave, Nicolas Dulphy, Valeria Bisio

Get full text

Very long-term remission with azacitidine in VEXAS syndrome by Lin-Pierre Zhao, Vincent Jachiet, Olivier Kosmider, Lise Larcher, Emmanuelle Clappier, Marie Sébert, Lionel Adès, Pierre Hirsch, Thibault Mahévas, Maxime Battistella, Jean-David Bouaziz, Arsène Mekinian, Pierre Fenaux, MINHEMON FRENVEX

Get full text

Prognostic significance of monocytic-like phenotype in patients with AML treated with venetoclax and azacytidine by Lin-Pierre Zhao, Typhaine Dumas-Rivero, Lauren Barette, Lorea Aguinaga, Arij Cheffai, Clémentine Chauvel, Reinaldo Dal Bello, Emmanuel Raffoux, Emmanuelle Clappier, Matthieu Duchmann, Pierre Fenaux, Pierre Lemaire, Stephanie Mathis, Marie Sébert, Lionel Adès, Raphaël Itzykson

Get full text

FLT3 ligand kinetic profile predicts response to treatment in patients with high-risk myelodysplastic syndrome / chronic myelomonocytic leukemia receiving CPX-351: a study from the... by Pierre Peterlin, Joëlle Gaschet, Pascal Turlure, Marie-Pierre Gourin, Pierre-Yves Dumas, Sylvain Thepot, Ana Berceanu, Sophie Park, Marie-Anne Hospital, Thomas Cluzeau, Jose-Miguel Torregrosa-Diaz, Louis Drevon, Rosa Sapena, Fatiha Chermat, Lionel Ades, Sophie Dimicoli-Salazar, Maxime Jullien, Pierre Fenaux, Patrice Chevallier.

Get full text

Infections in lower-risk myelodysplastic syndromes - prevalence and risk factors: a report from the European MDS Registry by Bente Houtman, Adele Taylor, Corine van Marrewijk, Alexandra Smith, Pierre Fenaux, Catherine Cargo, Argiris Symeonidis, Moshe Mittelman, Reinhard Stauder, Jaroslav Čermák, Guillermo Sanz, Eva Hellström-Lindberg, Luca Malcovati, Lionel Adès, Thibault Comont, Dominic Culligan, Ioannis Kotsianidis, Theo de Witte, Nicole Blijlevens, Saskia Langemeijer, Marlijn Hoeks, EUMDS Consortium

Get full text

High levels of global hydroxymethylation predict worse overall survival in MDS patients treated with azacitidine by Francesca Tiso, Florentien E. M. in 't Hout, Ruth Knops, Leonie I. Kroeze, Arno vanRooij, Arjan A. van deLoosdrecht, Theresia M. Westers, Saskia M. C. Langemeijer, Claude Preudhomme, Nicolas Duployez, Pierre Fenaux, Olivier Kosmider, Didier Bouscary, Aniek O. deGraaf, Joost H. A. Martens, Bert A. van derReijden, Lionel Adès, Michaela Fontenay, Joop H. Jansen

Get full text

Long-term real-world evidence of CPX-351 of high-risk patients with AML identified high rate of negative MRD and prolonged OS by Thomas Cluzeau, Fabio Guolo, Edmond Chiche, Paola Minetto, Ramy Rahme, Sarah Bertoli, Luana Fianchi, Jean-Baptiste Micol, Michele Gottardi, Pierre Peterlin, Sara Galimberti, Xavier Thomas, Giuliana Rizzuto, Olivier Legrand, Michela Rondoni, Emmanuel Raffoux, Giambattista Bertani, Alexis Caulier, Michelina D’Argenio, Caroline Bonmati, Atto Billio, Caroline Lejeune, Barbara Scappini, Arnaud Pigneux, Patrizia Zappasodi, Christan Recher, Francesco Grimaldi, Lionel Ades, Roberto M. Lemoli

Get full text

Fitness assessment in acute myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet by Adriano Venditti, Raffaele Palmieri, Luca Maurillo, Christoph Röllig, Agnieszka Wierzbowska, David de Leeuw, Fabio Efficace, Antonio Curti, Lok Lam Ngai, Jesse Tettero, Lionel Adès, Antonio Almeida, Lars Bullinger, Mike Dennis, Jordi Esteve, Felicetto Ferrara, Michael Heuser, Gerwin Huls, Michael Lübbert, Priyanka Mehta, Pau Montesinos, Thomas Pabst, Christian Récher, Giuseppe Rossi, Nigel Russell, Jorge Sierra, Reinhard Stauder, Norbert Vey, Roland B. Walter, Eunice Wang, Samantha Nier, Carolina Garcez Martins, Gert Ossenkoppele

Get full text

Long‐term follow‐up and combined Phase 2 results of eprenetapopt and azacitidine in patients with TP53 mutant MDS/AML by David A. Sallman, Rami S. Komrokji, Amy E. Dezern, Marie Sebert, Guillermo Garcia‐Manero, Ramy Rahmé, Eric S. Winer, Jacqueline Lehmann‐Che, Gail J. Roboz, Isabelle Madelaine, Mikkael A. Sekeres, Pierre Peterlin, Onyee Chan, Odile Beyne‐Rauzy, Andrew Kuykendall, Christian Recher, Amy McLemore, Aspasia Stamatoullas, Ling Zhang, Lise Willems, Qianxing Mo, Emmanuel Raffoux, Lisa Nardelli, Céline Berthon, Najla H. Al Ali, Bruno Quesnel, Eric Padron, Hagop M. Kantarjian, Alan F. List, Lionel Ades, Jeffrey E. Lancet, Pierre Fenaux, Thomas Cluzeau

Get full text

Somatic mutations and DNA methylation identify a subgroup of poor prognosis within lower‐risk myelodysplastic syndromes by David Rombaut, Sarah Sandmann, Tobias Tekath, Simon Crouch, Aniek O. deGraaf, Alexandra Smith, Daniel Painter, Olivier Kosmider, Magnus Tobiasson, Andreas Lennartsson, Bert A. van derReijden, Sophie Park, Maud D'Aveni, Borhane Slama, Emmanuelle Clappier, Pierre Fenaux, Lionel Adès, Arjan van deLoosdrecht, Saskia Langemeijer, Argiris Symeonidis, Jaroslav Čermák, Claude Preudhomme, Aleksandar Savic, Ulrich Germing, Reinhard Stauder, David Bowen, Corine vanMarrewijk, Elsa Bernard, Theo deWitte, Julian Varghese, Eva Hellström‐Lindberg, Martin Dugas, Joost Martens, Luca Malcovati, Joop H. Jansen, Michaela Fontenay, MDS‐RIGHT consortium

Get full text